Annovis Bio Inc Cash Flow-to-Debt Ratio
Annovis Bio Inc cash flow-to-debt ratio. Annovis Bio Inc (ANVS) has a Cash Flow-to-Debt Ratio of -0.69x as of March 2026, meaning its operating cash flow of $-9.01 Million could theoretically repay -1% of its total liabilities ($13.12 Million) in one year. See ANVS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Annovis Bio Inc (2009–2025)
Cash flow-to-debt ratio of Annovis Bio Inc from 2009 to 2025. Historical debt coverage capacity for Annovis Bio Inc across 13 annual periods. Check ANVS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annovis Bio Inc Cash Flow-to-Debt Ratio by Year (2009–2025)
Annovis Bio Inc cash flow-to-debt ratio by year from 2009 to 2025. Year-by-year debt coverage analysis for Annovis Bio Inc. For the full cash flow conversion analysis, see ANVS operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6056.13x | $-25.62 Billion | $4.23 Million | ▼ -27.7% |
| 2024 | -4741.16x | $-21.89 Billion | $4.62 Million | ▼ -212941.6% |
| 2023 | -2.23x | $-39.97 Million | $17.96 Million | ▲ +1.0% |
| 2022 | -2.25x | $-17.31 Million | $7.70 Million | ▲ +62.9% |
| 2021 | -6.06x | $-9.13 Million | $1.51 Million | ▲ +11.7% |
| 2020 | -6.87x | $-3.97 Million | $578.38K | ▼ -13865.2% |
| 2019 | -0.05x | $-476.54K | $9.69 Million | ▲ +32.7% |
| 2018 | -0.07x | $-558.61K | $7.64 Million | ▲ +0.4% |
| 2017 | -0.07x | $-537.48K | $7.32 Million | ▲ +99.1% |
| 2012 | -8.10x | $-1.41 Million | $174.36K | ▼ -1808.1% |
| 2011 | -0.42x | $-3.01 Million | $7.09 Million | ▼ -33.0% |
| 2010 | -0.32x | $-1.77 Million | $5.55 Million | ▲ +96.3% |
| 2009 | -8.56x | $-389.23K | $45.49K | — |